- Home
- AAOI vs ELVN Comparison
AAOI vs ELVN Comparison
Compare AAOI & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAOI
- ELVN
- Stock Information
- Founded
- AAOI 1997
- ELVN 2016
- Country
- AAOI United States
- ELVN United States
- Employees
- AAOI N/A
- ELVN N/A
- Industry
- AAOI Semiconductors
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- AAOI Technology
- ELVN Health Care
- Exchange
- AAOI Nasdaq
- ELVN Nasdaq
- Market Cap
- AAOI 950.4M
- ELVN 927.8M
- IPO Year
- AAOI 2013
- ELVN 2020
- Fundamental
- Price
- AAOI $25.65
- ELVN $21.36
- Analyst Decision
- AAOI Buy
- ELVN Strong Buy
- Analyst Count
- AAOI 4
- ELVN 5
- Target Price
- AAOI $25.50
- ELVN $39.60
- AVG Volume (30 Days)
- AAOI 5.8M
- ELVN 716.7K
- Earning Date
- AAOI 08-05-2025
- ELVN 08-12-2025
- Dividend Yield
- AAOI N/A
- ELVN N/A
- EPS Growth
- AAOI N/A
- ELVN N/A
- EPS
- AAOI N/A
- ELVN N/A
- Revenue
- AAOI $308,551,000.00
- ELVN N/A
- Revenue This Year
- AAOI $96.39
- ELVN N/A
- Revenue Next Year
- AAOI $53.81
- ELVN N/A
- P/E Ratio
- AAOI N/A
- ELVN N/A
- Revenue Growth
- AAOI 50.30
- ELVN N/A
- 52 Week Low
- AAOI $6.70
- ELVN $13.30
- 52 Week High
- AAOI $44.50
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- AAOI 71.94
- ELVN 55.84
- Support Level
- AAOI $25.28
- ELVN $20.22
- Resistance Level
- AAOI $28.01
- ELVN $24.11
- Average True Range (ATR)
- AAOI 2.26
- ELVN 1.69
- MACD
- AAOI 1.00
- ELVN -0.02
- Stochastic Oscillator
- AAOI 95.52
- ELVN 53.58
About AAOI Applied Optoelectronics Inc.
Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.